Obeldesivir is an isobutyric ester prodrug of GS-441524 made by Gilead Sciences that is currently in Phase III trials for the outpatient treatment of COVID-19 in high risk patients. From Wikipedia
The antiviral drug obeldesivir demonstrated high survival rates in infected monkeys, offering potential for easier and broader outbreak management.
